Kreocox TH 4 Tablet is a combination medication containing Etoricoxib 60 mg and Thiocolchicoside 4 mg, formulated for the management of musculoskeletal pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal disorders. Etoricoxib, a selective COX-2 inhibitor, provides effective anti-inflammatory and analgesic effects by selectively blocking the cyclooxygenase-2 enzyme, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation while minimizing gastrointestinal side effects commonly associated with non-selective NSAIDs. Thiocolchicoside is a muscle relaxant with anti-inflammatory properties that acts by antagonizing glycine receptors and modulating GABAergic transmission, resulting in the relief of muscle spasms and improvement in mobility. The combination of these two agents offers synergistic benefits, addressing both pain and muscle stiffness to enhance patient comfort and functional recovery. Kreocox TH 4 Tablet is indicated for short-term use under medical supervision, with caution advised in patients with cardiovascular risk factors, hepatic or renal impairment, and hypersensitivity to its components. It is contraindicated during pregnancy and lactation. Patients should adhere to prescribed dosages and consult healthcare professionals regarding potential drug interactions and adverse effects.